Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.200
-0.030-0.33%
Volume:33.11M
Turnover:305.99M
Market Cap:106.00B
PE:23.22
High:9.375
Open:9.330
Low:9.130
Close:9.230
52wk High:11.203
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.63
T/O Rate:0.29%
Dividend:0.29
Dividend Rate:3.15%
EPS(LYR):0.396
ROE:20.90%
ROA:10.70%
PB:2.42
PE(LYR):23.22
PS:2.90

Loading ...

CSPC Pharmaceutical - Docetaxel (albumin-bound) and Anbenitamab Granted Breakthrough Therapy Designation in China

THOMSON REUTERS
·
Jul 14

CSPC Pharmaceutical Group (SEHK:1093) Gains Attention On Pipeline Progress And AstraZeneca Tie Up

Simply Wall St.
·
Jul 14

CSPC Pharma Secures $25 Million R&D Milestone Payment from AstraZeneca Under Strategic Collaboration

Deep News
·
Jul 12

CSPC Secures US$25.00 Million R&D Milestone from AstraZeneca in Long-Acting Peptide Collaboration

Bulletin Express
·
Jul 10

CSPC Pharma Receives $25 Million R&D Milestone Payment from AstraZeneca Under Strategic Collaboration and Licensing Deal

Stock News
·
Jul 10

CSPC Pharma Receives USD 25 Million R&D Milestone Payment from Astrazeneca Under Collaboration Deal

Reuters
·
Jul 10

CSPC Pharmaceutical Group Stock Rises 3.4% in Hong Kong

Dow Jones
·
Jul 10

Bank of America Securities Foresees Valuation Re-rating for Chinese Pharma Sector Driven by Active Licensing Deals, Raises Innovent Bio Target to HK$119.2

Stock News
·
Jul 10

Movement Alert|CSPC Pharmaceutical Rises 3.19% in Regular Trading, Pharmaceutical Sector Strengthens Amid Dense Positive Catalysts

Market Focus
·
Jul 10

Investment Manager Reduces Stake in CSPC PHARMA, Selling Shares at HK$8 Each

Stock News
·
Jul 09

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

Dow Jones
·
Jul 08

CSPC Pharmaceutical Group initiates Phase II trial for ANGPTL3-targeting SYH2070 Injection in mixed hyperlipidaemia

Bulletin Express
·
Jul 07

CSPC Pharma Initiates Phase II Trial in China for SYH2070 Injection in Mixed Hyperlipidemia

Stock News
·
Jul 07

CSPC Pharmaceutical Initiates Phase II China Trial of Syh2070 Injection for Mixed Hyperlipidaemia

Reuters
·
Jul 07

Movement Alert|CSPC Pharmaceutical Declines 3.28% in Regular Trading, Trading at HK$8.04

Market Focus
·
Jul 07

CSPC Pharmaceutical Group (SEHK:1093) Expands AstraZeneca Ties, Is The Upside Already Priced In?

Simply Wall St.
·
Jul 07

CSPC Pharmaceutical Group Stock Rises 2.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Movement Alert|CSPC Pharmaceutical Rises 3.37% in Regular Trading, AstraZeneca Strategic Collaboration Worth Up to $1.77 Billion Continues to Boost Sentiment

Market Focus
·
Jul 06

CSPC Pharmaceutical Group Stock Advances 6.0% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 03